✦ LIBER ✦

Cellular cadmium responses in subpopulations T20 and T27 of human lung carcinoma A549 cells

✍ Scribed by Yu-Jian Kang; Sirkku T. Nuutero; Jeffrey A. Clapper; Patricia Jenkins; M. Duane Enger

Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 489 KB
Volume: 61
Category: Article
ISSN: 0300-483X
DOI: 10.1016/0300-483x(90)90020-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of cellular glutathione depletion

Effect of cellular glutathione depletion on cadmium-induced cytotoxicity in human lung carcinoma cells

✍ Yu -Jian Kang; M. Duane Eenger 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 693 KB

The effect of glutathione depletion on cellular toxicity of cadmium was investigated in a subpopulation (T27) of human lung carcinoma A549 cells with coordinately high glutathione levels and Cd++-resistance. Cellular glutathione levels were depleted by exposing the cells to diethyl maleate or buthio

Sterically hindered analogues of diacylg

Sterically hindered analogues of diacylglycerols. synthesis, binding to the phorbol ester receptor and metabolism in a549 human lung carcinoma cells

✍ Charles A. Laughton; Tracey D. Bradshaw; Andreas Gescher 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 512 KB

Modulation by staurosporine of phorbol-e

Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in a549 human lung-carcinoma cells

✍ Tracey D. Bradshaw; Andreas Gescher; George R. Pettit 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 711 KB

I 2-0-tetradecanoylphorbol-I 3-acetate (TPA) and bryostatin I are activators of protein kinase C (PKC). TPA is a potent inhibitor of the growth of A549 cells, while bryostatin I exerts a weak antiproliferative effect upon this cell line. We tested the hypothesis that the PKC inhibitor staurosporine

Metabolomic studies of human lung carcin

Metabolomic studies of human lung carcinoma cell lines using in vitro1H NMR of whole cells and cellular extracts

✍ M. Gottschalk; G. Ivanova; D. M. Collins; A. Eustace; R. O'Connor; D. F. Brougha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

A randomized, controlled phase III study

A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-α maintenance therapy or observation, in small cell lung carcinoma patients with complete responses

✍ Diego Tummarello; Davide Mari; Francesco Graziano; Pierpaolo Isidori; Gianluigi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

BACKGROUND. Studies of chemotherapy for